European version of 911 Emergency number is 112
"112 working everywhere in the EU is a nice present to all Europeans, and the timing is perfect: during the holiday season of hectic travel people will spend a lot of time in other EU countries. From now on I expect 112 to be an essential travel companion for holiday makers in every corner of the EU," said Viviane Redding, the EU Telecoms Commissioner.
Know about this if you ever travel to Europe, it's 112, not 911.
Doctor shortages: Emergency medicine specialists in short supply
Writing in the journal Academic Emergency Medicine, lead author Dr. Carlos A. Camargo of Massachusetts General Hospital estimates that it would take until 2019 to find enough fully-trained, board-certified emergency physicians to work in the 4,828 emergency departments that are open 24 hours a day. And that best-case projection assumes that no current doctors who meet those qualifications die or leave their jobs.
Not just primary care, but other specialists also in short supply.
FDA: New drugs for our increase in diabetes must be screened more closely for heart risks
"I think the FDA got this one right," said Dr. Steven Nissen, a Cleveland Clinic cardiologist who raised the diabetes concern two years ago with a study indicating a popular new drug increased the risk of heart attacks. The medication, Avandia, remains on the market amid continuing debate. But such drugs will have to clear a higher bar in the future, the FDA said.
Notice that the above quote is from the Cleveland Clinic of face transplant fame.
Why statins don't work in 20% of patients
Often hailed as "wonder drugs" for their ability to lower cholesterol and reduce heart attack risk, statins actually don't work that well in about 20 percent of users. Turns out, these people may have certain genetic mutations that lower the drugs' effectiveness, according to a new study from Duke University Medical Center.
Interesting study on a very popular type of medication, we have discussed this in our Medical Forum, there are also dangers here.
Drug which strengthens bones may help fight breast cancer
Those given infusions of Zometa along with chemo had a third more tumor shrinkage and as a result, were less likely to need their whole breast removed versus just the lump, said study leader Dr. Robert Coleman of the University of Sheffield in England.
This is only a partial study, not enough to change practice, but looks very hopeful. Interesting cross-use of drugs one might not expect.
Nine ways to spot a medicare sales scam
According to the National Association of Insurance Commissioners, here are nine marketing do's and don'ts that consumers need to know. Anyone who represents himself or herself as selling a Medicare policy:1) Must be licensed by the state. Check with your state's insurance department to make sure the salesperson is a licensed agent. Find a link to your state insurance department's Web page. 2) May not make unsolicited contacts with prospective beneficiaries, such as door-to-door sales, cold calls, or approaching you in a parking lot. 3) Must have an appointment in advance before coming to your home. 4) Must arrange with you in advance the type of products that will be discussed during a scheduled sales appointment. At the appointment, the salesperson may not try to sell you other types of insurance coverage than the type(s) agreed upon in advance. 5) May not try to sell you products that are not related to healthcare (like a life insurance policy or an annuity) during a sales or marketing presentation of a Medicare prescription drug or Medicare Advantage plan. 6) May not use certain healthcare settings, such as a doctor's office or a pharmacy, to attempt to sell you a plan. 7) May not use an educational event to attempt to sell you a plan. 8) May not offer you free meals at promotional or sales events. 9) May not offer you gifts or other promotional items whose value exceeds $15.
Obviously, this is a problem we should all know about, shame on those people who do this.
Prostate cancer deaths cut in half by radiation plus hormone therapy
MONDAY, Dec. 15 (HealthDay News) -- Men with locally advanced prostate cancer -- cancer that has spread beyond the wall of the prostate gland -- who undergo radiation plus long-term hormone treatment cut their risk of dying in half, a new study has found.
Big observation of what is working to combat death from this killer.
Dec 18 2008, 08:24 AM